Naturally occurring melanomas in dogs as models for non‐UV pathways of human melanomas

Spontaneously occurring melanomas are frequent in dogs. They appear at the same localizations as in humans, i.e. skin, mucosal sites, nail matrix and eyes. They display variable behaviors: tumors at oral localizations are more frequent and aggressive than at other anatomical sites. Interestingly, dog melanomas are associated with strong breed predispositions and overrepresentation of black‐coated dogs. Epidemiological analysis of 2350 affected dogs showed that poodles are at high risk of developing oral melanoma, while schnauzers or Beauce shepherds mostly developped cutaneous melanoma. Clinical and histopathological analyses were performed on a cohort of 153 cases with a 4‐yr follow‐up. Histopathological characterization showed that most canine tumors are intradermal and homologous to human rare morphological melanomas types – ‘nevocytoid type’ and ‘animal type’‐. Tumor cDNA sequencing data, obtained from 95 dogs for six genes, relevant to human melanoma classification, detected somatic mutations in oral melanoma, in NRAS and PTEN genes, at human hotspot sites, but not in BRAF. Altogether, these findings support the relevance of the dog model for comparative oncology of melanomas, especially for the elucidation of non‐UV induced pathways.

[1]  Chao Lu,et al.  Retrospective study , 2016, Medicine.

[2]  F. Demenais,et al.  Genital and anorectal mucosal melanoma is associated with cutaneous melanoma in patients and in families , 2013, The British journal of dermatology.

[3]  W. Vermi,et al.  Sinonasal mucosal melanoma: Molecular profile and therapeutic implications from a series of 32 cases , 2013, Head & neck.

[4]  K. Flaherty Throwing the kitchen sink at melanoma drug development , 2012, Pigment cell & melanoma research.

[5]  M. Birtwistle,et al.  Novel Somatic Mutations to PI3K Pathway Genes in Metastatic Melanoma , 2012, PloS one.

[6]  E. Ostrander Franklin H. Epstein Lecture. Both ends of the leash--the human links to good dogs with bad genes. , 2012, The New England journal of medicine.

[7]  D. Rigel,et al.  Risk factors for the development of primary cutaneous melanoma. , 2012, Dermatologic clinics.

[8]  F. Galibert,et al.  The MTAP-CDKN2A Locus Confers Susceptibility to a Naturally Occurring Canine Cancer , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[9]  J. Harbour The genetics of uveal melanoma: an emerging framework for targeted therapy , 2012, Pigment cell & melanoma research.

[10]  A. Hauschild,et al.  Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors , 2011, Melanoma research.

[11]  M. Bennett,et al.  Canine melanoma: a comparison with human pigmented epithelioid melanocytoma , 2011, International journal of dermatology.

[12]  W. Pavan,et al.  The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin , 2011, Pigment cell & melanoma research.

[13]  H. Sakai,et al.  Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas. , 2011, Veterinary and comparative oncology.

[14]  C. E. Alvarez,et al.  Dog models of naturally occurring cancer. , 2011, Trends in molecular medicine.

[15]  A. Motsinger-Reif,et al.  Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior , 2011, BMC Cancer.

[16]  L. Cerroni,et al.  Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases , 2011, Modern Pathology.

[17]  R. Scolyer,et al.  Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care , 2011, Molecular oncology.

[18]  A. Zembowicz,et al.  Blue nevi and variants: an update. , 2011, Archives of pathology & laboratory medicine.

[19]  M. Kiupel,et al.  Prognostic Markers for Canine Melanocytic Neoplasms , 2011, Veterinary pathology.

[20]  D. Schadendorf,et al.  Genetic and morphologic features for melanoma classification , 2010, Pigment cell & melanoma research.

[21]  E. Ostrander,et al.  Man's best friend becomes biology's best in show: genome analyses in the domestic dog. , 2010, Annual review of genetics.

[22]  L. Lembcke,et al.  A novel locus for canine osteosarcoma (OSA1) maps to CFA34, the canine orthologue of human 3q26. , 2010, Genomics.

[23]  M. Miteva,et al.  Spitz nevus and atypical spitzoid neoplasm. , 2010, Seminars in cutaneous medicine and surgery.

[24]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[25]  Catherine André,et al.  Coat Variation in the Domestic Dog Is Governed by Variants in Three Genes , 2009, Science.

[26]  C. Khanna,et al.  Catching Cancer by the Tail: New Perspectives on the Use of Kinase Inhibitors , 2009, Clinical Cancer Research.

[27]  M. Kashani-Sabet,et al.  Melanoma arising in African-, Asian-, Latino- and Native-American populations. , 2009, Seminars in cutaneous medicine and surgery.

[28]  C. Langford,et al.  ‘Putting our heads together’: insights into genomic conservation between human and canine intracranial tumors , 2009, Journal of Neuro-Oncology.

[29]  K. Chalvet-Monfray,et al.  Genetic and environmental risk indicators in canine non-Hodgkin's lymphomas: breed associations and geographic distribution of 608 cases diagnosed throughout France over 1 year. , 2009, Journal of veterinary internal medicine.

[30]  J. Rees Melanoma: What Are the Gaps in Our Knowledge? , 2008, PLoS medicine.

[31]  J. Hansson,et al.  Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site , 2008, Molecular oncology.

[32]  K. Flaherty,et al.  The MAPK pathway in melanoma , 2008, Current Opinion in Oncology.

[33]  F. Galibert,et al.  The dog: A powerful model for studying genotype-phenotype relationships. , 2008, Comparative biochemistry and physiology. Part D, Genomics & proteomics.

[34]  F. Luciani,et al.  Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. , 2007, Genes & development.

[35]  E. Kirkness,et al.  Breed relationships facilitate fine-mapping studies: a 7.8-kb deletion cosegregates with Collie eye anomaly across multiple dog breeds. , 2007, Genome research.

[36]  K. Lindblad-Toh,et al.  Efficient mapping of mendelian traits in dogs through genome-wide association , 2007, Nature Genetics.

[37]  P. Bergman Canine oral melanoma. , 2007, Clinical techniques in small animal practice.

[38]  J. Messina,et al.  Primary mucosal melanoma. , 2007, Journal of the American Academy of Dermatology.

[39]  Hugh M Gloster,et al.  Skin cancer in skin of color. , 2006, Journal of the American Academy of Dermatology.

[40]  P. Kass,et al.  The Histologic and Epidemiologic Bases for Prognostic Considerations in Canine Melanocytic Neoplasia , 2006, Veterinary pathology.

[41]  James A. Cuff,et al.  Genome sequence, comparative analysis and haplotype structure of the domestic dog , 2005, Nature.

[42]  D. Heffel,et al.  Congenital melanosis: an update. , 2005, The Journal of craniofacial surgery.

[43]  J. McCallan,et al.  Exon 15 BRAF mutations are uncommon in canine oral malignant melanomas , 2005, Mammalian Genome.

[44]  J. Cigudosa,et al.  Molecular alterations associated with cyclin d1 overexpression in endometrial cancer , 2004, International journal of cancer.

[45]  M. Mihm,et al.  Pigmented Epithelioid Melanocytoma: A Low-grade Melanocytic Tumor With Metastatic Potential Indistinguishable From Animal-type Melanoma and Epithelioid Blue Nevus , 2004, The American journal of surgical pathology.

[46]  M. Goldschmidt,et al.  A Comparative Review of Melanocytic Neoplasms , 2002, Veterinary pathology.

[47]  M. Miller,et al.  Retrospective Study of 338 Canine Oral Melanomas with Clinical, Histologic, and Immunohistochemical Review of 129 Cases , 2000, Veterinary pathology.

[48]  Erwin G. Van Meir,et al.  p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma , 2000, Oncogene.

[49]  J. Yokota,et al.  Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers , 1998, Genes, chromosomes & cancer.

[50]  R. Peiffer,et al.  Morphology and Behavior of Primary Ocular Melanomas in 91 Dogs , 1986, Veterinary pathology.

[51]  M. Wigler,et al.  Structure and activation of the human N-ras gene , 1983, Cell.

[52]  J. Belmont,et al.  CCDC39 is required for assembly of inner dynein arms and the dynein regulatory complex and for normal ciliary motility in humans and dogs , 2011, Nature Genetics.

[53]  D. Pinkel,et al.  Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. , 2007, The Journal of investigative dermatology.

[54]  Cdm Fletcher,et al.  World Health Organization Classification of Tumours , 2002 .

[55]  M. Goldschmidt Histological classification of epithelial and melanocytic tumors of the skin of domestic animals , 1998 .

[56]  F. Galibert,et al.  Nature Genetics Advance Online Publication Pnpla1 Mutations Cause Autosomal Recessive Congenital Ichthyosis in Golden Retriever Dogs and Humans , 2022 .